These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1824888

  • 1. Synergistic effect of the rapamycin-cyclosporine combination: median effect analysis of in vitro immune performances by human T lymphocytes in PHA, CD3, and MLR proliferative and cytotoxicity assays.
    Kahan BD, Gibbons S, Tejpal N, Chou TC, Stepkowski S.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1090-1. PubMed ID: 1824888
    [No Abstract] [Full Text] [Related]

  • 2. Evidence for a cyclosporine-resistant pathway of T cell activation triggered via the CD3/T cell receptor complex.
    Schlitt HJ, Schwinzer R, Kurrle R, Wonigeit K.
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):103-9. PubMed ID: 2966472
    [No Abstract] [Full Text] [Related]

  • 3. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ, Christians U, Wonigeit K, Sewing KF, Pichlmayr R.
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract] [Full Text] [Related]

  • 4. Additive effect of cyclosporine and verapamil on the inhibition of activation and function of human peripheral blood mononuclear cells.
    Weir MR, Peppler R, Gomolka D, Handwerger BS.
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):240-4. PubMed ID: 2966479
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A.
    Sigal NH, Lin CS, Siekierka JJ.
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):1-5. PubMed ID: 1712132
    [No Abstract] [Full Text] [Related]

  • 6. Cloning of human CD3+ T cells and CD3- natural killer cells and requirements for long-term expansion.
    van de Griend RJ, Goedegebuure SP, van Krimpen BA, Bolhuis RL.
    Transplant Proc; 1988 Apr; 20(2):149-54. PubMed ID: 2966464
    [No Abstract] [Full Text] [Related]

  • 7. Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression.
    Kimball PM, Kerman RH, Kahan BD.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1027-8. PubMed ID: 1989147
    [No Abstract] [Full Text] [Related]

  • 8. Cyclosporine inhibits T-cell activation at two distinct levels: role of the CD 28 activation pathway.
    Hess AD, Bright EC.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):961-6. PubMed ID: 1846483
    [No Abstract] [Full Text] [Related]

  • 9. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
    Comoli P, Montagna D, Moretta A, Zecca M, Locatelli F, Maccario R.
    J Immunol; 1995 Dec 15; 155(12):5506-11. PubMed ID: 7499831
    [Abstract] [Full Text] [Related]

  • 10. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine.
    Kimball PM, Kerman RH, Kahan BD.
    Transplantation; 1991 Feb 15; 51(2):486-90. PubMed ID: 1825247
    [Abstract] [Full Text] [Related]

  • 11. Nicardipine enhances the effect of cyclosporine A on T lymphocyte activation in vitro.
    van Eendenburg JP, Brisson E, Klatzmann D, Gluckman JC.
    Transplant Proc; 1988 Apr 15; 20(2 Suppl 2):245-52. PubMed ID: 3129843
    [No Abstract] [Full Text] [Related]

  • 12. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J, Wisniewski D, Gulati S, Welte K, Knowles R, Clarkson B.
    Nat Immun Cell Growth Regul; 1987 Apr 15; 6(3):129-40. PubMed ID: 3114621
    [Abstract] [Full Text] [Related]

  • 13. Two-signal model for T-cell activation: molecular mechanisms.
    Sehajpal PK, Sharma VK, Stenzel KH, Suthanthiran M.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):104-5. PubMed ID: 8094907
    [No Abstract] [Full Text] [Related]

  • 14. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W, Reed JC, Nowell PC, Kamoun M.
    J Immunol; 1985 Mar 15; 134(3):1709-16. PubMed ID: 2981919
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxic T lymphocyte triggering via CD16 is regulated by CD3 and CD8 antigens. Studies with T cell receptor (TCR)-alpha beta+/CD3+16+ and TCR-gamma delta+/CD3+16+ granular lymphocytes.
    Oshimi K, Oshimi Y, Yamada O, Wada M, Hara T, Mizoguchi H.
    J Immunol; 1990 May 01; 144(9):3312-7. PubMed ID: 2139452
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synergisms between different activation pathways in adult and aged human lymphocytes.
    Borghi MO, Barcellini W, Ferraro G, Vismara A, Meroni PL.
    J Clin Lab Immunol; 1989 Jul 01; 29(3):133-9. PubMed ID: 2534484
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence that rapamycin inhibits interleukin-12-induced proliferation of activated T lymphocytes.
    Bertagnolli MM, Yang L, Herrmann SH, Kirkman RL.
    Transplantation; 1994 Nov 27; 58(10):1091-6. PubMed ID: 7974715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.